Cargando…

How Far Are We from Prescribing Fasting as Anticancer Medicine?

(1) Background: the present review provides a comprehensive and up-to date overview of the potential exploitation of fasting as an anticancer strategy. The rationale for this concept is that fasting elicits a differential stress response in the setting of unfavorable conditions, empowering the survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deligiorgi, Maria V., Liapi, Charis, Trafalis, Dimitrios T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730661/ https://www.ncbi.nlm.nih.gov/pubmed/33271979 http://dx.doi.org/10.3390/ijms21239175

Ejemplares similares

The Intriguing Thyroid Hormones–Lung Cancer Association as Exemplification of the Thyroid Hormones–Cancer Association: Three Decades of Evolving Research
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum
por: Deligiorgi, Maria V., et al.
Publicado: (2022)

A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Deligiorgi, Maria V., et al.
Publicado: (2023)

The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

Assessment of Methodological Pipelines for the Determination of Isothiocyanates Derived from Natural Sources
por: Kyriakou, Sotiris, et al.
Publicado: (2022)

Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation
por: Trafalis, Dimitrios T., et al.
Publicado: (2021)

Spondyloarthritis: How far are we from precision medicine?
por: So, Jacqueline, et al.
Publicado: (2022)

Chemical and Biological Characterization of the Anticancer Potency of Salvia fruticosa in a Model of Human Malignant Melanoma
por: Kyriakou, Sotiris, et al.
Publicado: (2021)

Precision Medicine in Solid Tumors: How Far We Traveled So Far?
por: Dey, Nandini, et al.
Publicado: (2022)

Neuro-Nutraceutical Polyphenols: How Far Are We?
por: Gentile, Maria Teresa, et al.
Publicado: (2023)

Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden
por: Sagredou, Sofia, et al.
Publicado: (2021)

The role of metabolomics in precision medicine of osteoarthritis: How far are we?
por: Zhai, Guangju
Publicado: (2021)

Thermophilic biohydrogen production: how far are we?
por: Pawar, Sudhanshu S., et al.
Publicado: (2013)

Gene Delivery to the Skin – How Far Have We Come?
por: Ain, Qurrat Ul, et al.
Publicado: (2021)

Candida glabrata Biofilms: How Far Have We Come?
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019)

Ras Isoforms from Lab Benches to Lives—What Are We Missing and How Far Are We?
por: Nair, Arathi, et al.
Publicado: (2021)

Omics in Clinical Practice: How Far Are We?
por: Sáez, María Eugenia
Publicado: (2022)

How Far Will We See in the Future?
por: Nasmyth, Kim
Publicado: (2010)

Overcoming Shellfish Allergy: How Far Have We Come? †
por: Wai, Christine Y.Y., et al.
Publicado: (2020)

Imaging of the unstable plaque: how far have we got?
por: Matter, Christian M., et al.
Publicado: (2009)

Aquaporins as diagnostic and therapeutic targets in cancer: How far we are?
por: Wang, Jian, et al.
Publicado: (2015)

Understanding Bioluminescence in Dinoflagellates—How Far Have We Come?
por: Valiadi, Martha, et al.
Publicado: (2013)

Drug Repurposing for Viral Infectious Diseases: How Far Are We?
por: Mercorelli, Beatrice, et al.
Publicado: (2018)

Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
por: Polito, Letizia, et al.
Publicado: (2021)

Calcium imaging analysis – how far have we come?
por: Robbins, Miranda, et al.
Publicado: (2021)

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)

Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023)

Understanding the underlying mechanisms governing spindle orientation: How far are we from there?
por: Zhong, Tao, et al.
Publicado: (2022)

Cardiac Telocytes 16 Years on—What Have We Learned So Far, and How Close Are We to Routine Application of the Knowledge in Cardiovascular Regenerative Medicine?
por: Klein, Martin, et al.
Publicado: (2021)

Anaplastic thyroid cancer: How far can we go?
por: Amaral, Mariana, et al.
Publicado: (2020)

Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Genetic Approaches for Sports Performance: How Far Away Are We?
por: Joyner, Michael J.
Publicado: (2019)

An Evaluation of the Anti-Carcinogenic Response of Major Isothiocyanates in Non-Metastatic and Metastatic Melanoma Cells
por: Mitsiogianni, Melina, et al.
Publicado: (2021)

Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
por: Adlard, Paul A., et al.
Publicado: (2018)

Surface Enhanced Raman Spectroscopy for DNA Biosensors—How Far Are We?
por: Pyrak, Edyta, et al.
Publicado: (2019)

Computational modelling for congenital heart disease: how far are we from clinical translation?
por: Biglino, Giovanni, et al.
Publicado: (2017)

How Far Can We Hear with the Telephone?
Publicado: (1879)

How Far Are We from the Completion of the Human Protein Interactome Reconstruction?
por: Dimitrakopoulos, Georgios N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cne49sss56kq3ttbs5kamnadd